A multicenter study of niraparib as maintenance therapy in BRCA wild-type, newly diagnosed advanced ovarian cancer (Polo trial)

被引：0
|
作者：
Kim, Se Ik [1 ]
Choi, Chel Hun [2 ]
Kim, Ji Hyun [3 ,4 ]
Lee, Yong Jae [5 ]
Park, Jeong-Yeol [6 ]
Suh, Dong Hoon [7 ]
Kim, Yong Beom [7 ]
Lee, Jung-Yun [5 ]
Lim, Myong Cheol [3 ,4 ]
Kim, Byoung Gie [2 ]
Kim, Jae-Weon [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea
[2] Sungkyunkwan Univ, Dept Obstet & Gynecol, Sch Med, Samsung Med Ctr, Seoul, South Korea
[3] Natl Canc Ctr, Ctr Gynecol Canc, Goyang Si, South Korea
[4] Ctr Clin Trial, Goyang Si, South Korea
[5] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Dept Obstet & Gynecol, Seoul, South Korea
[6] Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
[7] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Seongnam Si, South Korea
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷 / SUPPL_4期
关键词：
D O I：
10.1136/ijgc-2023-IGCS.476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TP016
引用
收藏
页码：A252 / A252
页数：1
相关论文
共 50 条
  • [41] Maintenance Olaparib in Patients With Newly Diagnosed Advanced Ovarian Cancer EDITORIAL COMMENT
    不详
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2019, 74 (02) : 86 - 87
  • [42] Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer: Time for a Paradigm Shift?
    DiSilvestro, Paul
    Colombo, Nicoletta
    Harter, Philipp
    Gonzalez-Martin, Antonio
    Ray-Coquard, Isabelle
    Coleman, Robert L.
    CANCERS, 2021, 13 (22)
  • [43] Starting dose of niraparib as first-line maintenance among patients with newly diagnosed advanced ovarian cancer in a real-world database
    Liu, Jinan
    Thaker, Premal
    Song, Jinlin
    Kalilani, Linda
    Guo, Helen
    Wu, Eric
    Hurteau, Jean
    Chan, John
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S180 - S180
  • [44] NIRAPARIB THERAPY IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED OVARIAN CANCER AFTER CHEMOTHERAPY: PRIMA/ENGOT-OV26/GOG-3012 STUDY
    Gonzalez-Martin, A.
    Pothuri, B.
    Vergote, I.
    Christensen, R. D.
    Graybill, W.
    Mirza, M. R.
    McCormick, C.
    Lorusso, D.
    Hoskins, P.
    Freyer, G.
    Baumann, K.
    Jardon, K.
    Redondo, A.
    Moore, R. G.
    Vulsteke, C.
    O'Cearbhaill, R. E.
    Lund, B.
    Backes, F.
    Barretina-Ginesta, P.
    Haggerty, A. F.
    Rubio-Perez, M. J.
    Shahin, M. S.
    Mangili, G.
    Bradley, W. H.
    Bruchim, I.
    Sun, K.
    Malinowska, I.
    Li, Y.
    Gupta, D.
    Monk, B. J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A9 - A10
  • [45] Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis
    Lee, Banghyun
    Chang, Suk-Joon
    Kwon, Byung Su
    Son, Joo-Hyuk
    Lim, Myong Cheol
    Kim, Yun Hwan
    Lee, Shin-Wha
    Choi, Chel Hun
    Eoh, Kyung Jin
    Lee, Jung-Yun
    Suh, Dong Hoon
    Kim, Yong Beom
    PLOS ONE, 2023, 18 (11):
  • [46] MAINTENANCE OLAPARIB IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED OVARIAN CANCER AND A BRCA MUTATION: SUBGROUP ANALYSIS BY RISK IN THE PHASE III SOLO1 STUDY
    Colombo, Nicoletta
    Bradley, William
    Moore, Kathleen
    Gonzalez-Martin, Antonio
    Scambia, Giovanni
    Oaknin, Ana
    Friedlander, Michael
    Lowe, Elizabeth
    Rowe, Phil
    Disilvestro, Paul
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A76 - A77
  • [47] Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ ENGOT-OV26/GOG-3012 trial
    Monk, B. J.
    Barretina-Ginesta, M. P.
    Pothuri, B.
    Vergote, I.
    Graybill, W.
    Mirza, M. R.
    Mccormicky, C. C.
    Lorusso, D.
    Moore, R. G.
    Freyer, G.
    O'Cearbhaill, R. E.
    Heitz, F.
    O'Malley, D. M.
    Redondo, A.
    Shahin, M. S.
    Vulsteke, C.
    Bradley, W. H.
    Haslund, C. A.
    Chase, D. M.
    Pisano, C.
    Holman, L. L.
    Perez, M. J. Rubio
    Disilvestro, P.
    Gaba, L.
    Herzog, T. J.
    Bruchim, I.
    Compton, N.
    Shtessel, L.
    Malinowska, I. A.
    Gonzalez-Martin, A.
    ANNALS OF ONCOLOGY, 2024, 35 (11) : 981 - 992
  • [48] EFFICACY OF NIRAPARIB THERAPY IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED OVARIAN CANCER BY BRCAWT STATUS: PRIMA/ENGOT-OV26/GOG-3012 STUDY
    Braicu, Elena Ioana
    Pothuri, Bhavana
    Alejandro Perez-Fidalgo, Jose
    O'malley, David
    Honhon, Brigitte
    Graybill, Whitney
    Fabbro, Michel
    Dahlstrand, Hanna
    Gupta, Divya
    Monk, Bradley J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A70 - A71
  • [49] EFFICACY OF MAINTENANCE WITH PARPI IN ADVANCED OVARIAN CANCER ACCORDING TO THE TYPE OF BRCA MUTATION
    Marchetti, Claudia
    Fagotti, Anna
    Fruscio, Robert
    Cassani, Chiara
    Incorvaia, Lorena
    Perri, Maria Teresa
    Sassu, Carolina Maria
    Seca, Maria
    Camnasio, Cristina Angela
    Giudice, Elena
    Minucci, Angelo
    Arbustini, Eloisa
    Vertechy, Laura
    Boccia, Serena Maria
    Salutari, Vanda
    Ferrandina, Maria Gabriella
    Musacchio, Lucia
    Russo, Antonio
    Scambia, Giovanni
    Lorusso, Domenica
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A26 - A26
  • [50] Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy.
    Yin, Rutie
    Li, Ning
    Wu, Lingying
    Wang, Jing
    Zhu, Jianqing
    Pan, Lingya
    Kong, Beihua
    Zheng, Hong
    Liu, Jihong
    Wu, Xiaohua
    Wang, Li
    Huang, Yi
    Wang, Ke
    Zou, Dongling
    Zhao, Hongqin
    Wang, Chunyan
    Lu, Weiguo
    Zhen, Xiaoa
    Hang, Wenzhao
    Hou, Jianmei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345